Navigation Links
Warner Chilcott to Present at the Goldman Sachs Leveraged Finance Healthcare Conference
Date:3/4/2011

DUBLIN, Ireland, March 4, 2011 /PRNewswire/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that its Executive Vice President and Chief Financial Officer Paul Herendeen is scheduled to speak at the Goldman Sachs Leveraged Finance Healthcare Conference on Tuesday, March 8th at 12:35 p.m. ET.  

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the North American and Western European pharmaceuticals markets.  The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products.  WCRX-G


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Warner Chilcott Seeks to Refinance its Existing Credit Agreement
2. Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010
3. Warner Chilcott to Present at the Citi 2011 Global Health Care Conference
4. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2010 Financial Results
5. Warner Chilcott to Present at the 29th Annual J.P. Morgan Healthcare Conference
6. Warner Chilcott to Present at the Bank of America Merrill Lynch Credit Conference
7. Warner Chilcott Announces FDA Approval of New Oral Contraceptive
8. Warner Chilcott Completes Acquisition of U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
9. Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations
10. TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
11. Warner Chilcott Announces FDA Approval of Next Generation Actonel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... Dec. 3, 2016 A highly innovative, personalized cell-based treatment for ... through clinical trials. Pediatric oncologists from Children,s Hospital of Philadelphia ... or refractory acute lymphoblastic leukemia (ALL). The physician-scientists presented findings ... San Diego . ... ...
(Date:12/2/2016)... The U.S. Food and Drug Administration today ... the risk of cardiovascular death in adult patients with ... "Cardiovascular disease is a leading cause of death ... Jean-Marc Guettier , M.D., C.M., director of the Division ... Drug Evaluation and Research. "Availability of antidiabetes therapies that ...
(Date:12/2/2016)... -- Persistence Market Research (PMR) delivers key ... titled, "Global Market Study on Cardiac Pacemaker: North America Regional ... 2016 and 2024". The global cardiac pacemaker market was valued ... likely to decline to US$ 3923.8 Mn by 2024. ... is anticipated to exhibit a declining CAGR of -0.5% ...
Breaking Medicine Technology:
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... Responsible dental ... One must brush properly to achieve optimal results. This important necessity inspired an inventor ... need for a way to ensure that people break or avoid bad techniques of ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... Lori ... Greenberg Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st ... Greenberg Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs ...
(Date:12/2/2016)... DIEGO, Calif. (PRWEB) , ... December 02, 2016 , ... ... Event at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals ... myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Area in Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. ... scholarship funds for area students and operating support to UNCF-member institutions, including Miles ...
Breaking Medicine News(10 mins):